Agenus Inc.
AGENNASDAQHealthcareBiotechnology
As of Oct 16, 2026 close
- Market cap
- $276.14M
- P/E (TTM)
- 3.00
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $2.71$10.31
- Volume (live)
- -
- Avg. volume (3M)
- 1.11M
Agenus (AGEN) Stock Price & Financial Analysis
Agenus Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $6.00 - $6.70 |
|---|---|
| 52-Week High | $10.31 |
| 52-Week Low | $2.71 |
| Open | $6.65 |
| Volume (last close) | 1.03M |
| Average Volume (3M) | 1.11M |
| Revenue (TTM) | 132.69M |
|---|---|
| Net Income (TTM) | 92.01M |
| Free Cash Flow (TTM) | -98.50M |
| EPS (TTM) | $2.49 |
| Profit Margin | 69.34% |
| Operating Margin | 27.28% |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
| Payout Ratio | 0.00% |
| Market Cap | 276.14M |
|---|---|
| Shares Outstanding | 41.34M |
| P/E Ratio (TTM) | 3.00 |
| Price to Sales (P/S) | 2.08 |
| Price to Book (P/B) | -1.34 |
| EV/EBITDA | 1.96 |
| 50-Day MA | $7.77 |
|---|---|
| 200-Day MA | $4.76 |
| 1-Year Change | +72.16% |
Source: Market prices and company fundamentals. Data as of Oct 16, 2026. Data sources and methodology
Agenus at a Glance
As of the Oct 16, 2026 close, Agenus (AGEN) has a market capitalization of $276.14M. The stock trades at 3.0× trailing earnings and 2.1× sales. Over the trailing twelve months it earned $92.01M on revenue of $132.69M (a 69.3% profit margin) and burned $98.50M of free cash flow. Revenue grew 30.5% year over year.
As of its latest reported balance sheet, it holds $18.74M in cash and securities against $40.71M of debt, a net debt position of $21.97M.
Agenus does not currently pay a dividend.
The share price is up 72.2% over the past year. At $6.04 (the Oct 16, 2026 close) it sits within its 52-week range of $2.71 to $10.31, above its 200-day moving average of $4.76.
Based on 2 professional analyst ratings from the past 90 days, the consensus is Hold.
Frequently Asked Questions About Agenus
What is the current stock price for AGEN?
As of the Oct 16, 2026 close, AGEN stock trades at $6.04. The 52-week range is $2.71–$10.31, with a day range of $6.00–$6.70.
What is the P/E ratio for AGEN?
As of the Oct 16, 2026 close, Agenus's trailing twelve-month (TTM) P/E ratio is 3.0, meaning investors pay $3.0 for every $1 of annual earnings. Agenus operates in the Healthcare sector.
Does AGEN pay dividends?
Agenus does not currently pay a regular dividend. The company retains its earnings to reinvest in the business. Check the Dividends tab for historical dividend information.
What do analysts recommend for AGEN?
Based on ratings from 2 professional analysts over the last 90 days, the consensus for AGEN is Hold.
What is the market cap of AGEN?
As of the Oct 16, 2026 close, Agenus's market capitalization is $249.7M, classifying it as a micro-cap company. Agenus operates in the Healthcare sector within the Biotechnology industry.